To further investigate the clinical significance of MEX3A modulation in CRC patients, we assessed the RNA expression levels of MEX3A, circMPP6, and downstream PDE5A in CRC tissues from TCGA and SYSUCC cohorts. This evidence concerns the gene MEX3A and colorectal carcinoma.